Lexeo Therapeutics, Inc. - LXEO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$897.7M
QoQ value delta ($000)
+$570.4M (+174.3%)
Implied price effect (QoQ)
+76.79%
Shares
Total shares
76,488,647
QoQ shares delta
+27,190,010 (+55.15%)
Total shares held by funds (by quarter)

Market chart (LXEO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 7 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CAXTON CORP 138,453 13,943 3.24%
JANUS HENDERSON GROUP PLC 54,668 5,509,635 0.02%
RA CAPITAL MANAGEMENT, L.P. 49,650 5,000,000 0.51%
BlackRock, Inc. 48,732 4,907,563 0.0%
Paradigm Biocapital Advisors LP 47,298 4,763,198 1.21%
Vestal Point Capital, LP 44,436 4,475,000 1.51%
Frazier Life Sciences Management, L.P. 43,937 4,424,725 1.18%
VANGUARD GROUP INC 38,670 3,894,310 0.0%
CITADEL ADVISORS LLC 37,478 3,774,317 0.01%
Avoro Capital Advisors LLC 32,769 3,300,000 0.32%
Affinity Asset Advisors, LLC 31,776 3,200,000 1.81%
Woodline Partners LP 31,753 3,197,760 0.12%
STATE STREET CORP 31,654 3,187,722 0.0%
ORBIMED ADVISORS LLC 21,101 2,125,000 0.43%
Point72 Asset Management, L.P. 18,814 1,894,722 0.02%
Octagon Capital Advisors LP 17,129 1,725,000 2.08%
BALYASNY ASSET MANAGEMENT L.P. 16,235 1,635,026 0.02%
GEODE CAPITAL MANAGEMENT, LLC 14,361 1,445,887 0.0%
ADAR1 Capital Management, LLC 13,834 1,393,161 1.02%
SUVRETTA CAPITAL MANAGEMENT, LLC 12,412 1,250,000 0.25%
683 Capital Management, LLC 11,121 1,120,000 0.48%
Nantahala Capital Management, LLC 9,930 1,000,000 0.33%
MILLENNIUM MANAGEMENT LLC 9,016 908,024 0.0%
Blackstone Inc. 8,986 904,959 0.04%
DIMENSIONAL FUND ADVISORS LP 8,567 862,892 0.0%